X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-28 | RPTX | Segal Lloyd Mitchell | Pres, CEO | S - Sale | $4.62 | -5,141 | 210,236 | -2% | -$23,776 | |||||
| M | 2024-03-28 | RPTX | Forte Steve | EVP, CFO | S - Sale | $4.62 | -1,614 | 44,775 | -3% | -$7,449 | |||||
| M | 2024-03-28 | RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S - Sale | $4.65 | -860 | 71,908 | -1% | -$3,999 | |||||
| M | 2024-03-28 | RPTX | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S - Sale | $4.65 | -800 | 231,409 | 0% | -$3,718 | |||||
| M | 2024-03-25 | RPTX | Forte Steve | EVP, CFO | S - Sale | $4.67 | -2,475 | 42,212 | -6% | -$11,558 | |||||
| M | 2024-03-25 | RPTX | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | S - Sale | $4.67 | -1,350 | 72,768 | -2% | -$6,305 | |||||
| M | 2024-03-25 | RPTX | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | S - Sale | $4.67 | -1,500 | 232,209 | -1% | -$7,000 | |||||
| M | 2024-03-25 | RPTX | Segal Lloyd Mitchell | Pres, CEO | S - Sale | $4.69 | -7,950 | 208,543 | -4% | -$37,259 | |||||
| M | 2023-11-15 | RPTX | Bvf Partners L P/il | 10% | P - Purchase | $5.09 | +1,227,301 | 548,938 | -181% | +$6,249,889 | |||||
2023-11-02 | RPTX | Bvf Partners L P/il | 10% | P - Purchase | $3.60 | +783,709 | 485,083 | -262% | +$2,821,352 | ||||||
| M | 2023-06-07 | RPTX | Zinda Michael | EVP, Chief Scientific Officer | S - Sale | $12.03 | -9,273 | 60,118 | -13% | -$111,526 | |||||
2023-06-06 | RPTX | Zinda Michael | EVP, Chief Scientific Officer | S - Sale | $12.04 | -1,200 | 69,391 | -2% | -$14,448 | ||||||
2022-12-09 | RPTX | Jerel Davis | Dir | S - Sale | $16.00 | -250,000 | 3,315,739 | -7% | -$4,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |